On the other hand, we successfully demonstrated the interplay between miR-342 and the two genes in MDA-MB-231 cells that share the features of the clinical “triple negative” tumor type for their ER, PR and HER2 negative status, and have been classified in the basal B subtype based on their transcriptional profile [47], [48]. This evidence concerns the gene ERBB2 and neoplasm.